Thanks to our sponsors for their continuing support...
The RTP DMDG is a tax-exempt, non-profit organization and does not charge membership fees. Meetings are funded in part through registration fees, but these fees do not cover the travel costs of speakers and venue fees. The organization exists because of generous corporate support.
Because of this financial support, the RTP-DMDG has become a venue where new and experienced scientists in drug metabolism, toxicology, and clinical pharmacology meet to network, share expertise, and acquire knowledge. Corporate sponsors are listed below and are recognized at all meetings during the year of their donation.
If you or your company are interested in supporting the RTP DMDG through a tax-deductible contribution, contact us at rtpdmdg.owner@rtpdmdg.org.
XenoTech - Sekisui
XenoTech, LLC is a global Contract Research Organization with unparalleled experience and expertise in evaluating drug candidates, nutraceuticals, cosmetics, food additives and other compounds widely known as xenobiotics, substrates, inhibitors and inducers of cytochrome P450, UGT and other drug metabolizing enzymes and drug transporters. The company offers a variety of in vitro and in vivo safety assessment studies for drug candidate evaluation, as well as an extensive selection of products for drug metabolism research. XenoTech's product selection includes a wide-range of high quality standard reagents, from subcellular fractions and hepatocytes to recombinant enzymes, substrates and metabolites. The company can also prepare and deliver custom-designed products and services in respnose to client requests. For additional information, please refer to the company's website at www.xenotechllc.com or call (913) 438-7450.
Bioreclamation IVT
BioIVT is a worldwide provider of biological products to life sciences and pharmaceutical companies. We specialize in control and disease state matrices manufactured from human and animal blood, plasma and serum, which are used in drug discovery, compound development, clinical and research diagnostics. BioIVT's products enable scientists and biomedical researchers to better understand the pharmacokinetics and drug metabolism of newly discovered compounds and the effects on disease processes.
BioIVT is the premier world provider of specialized in vitro products for the study of metabolism, drug-drug interactions and toxicity in drug discovery and development. Since 1990, pharmaceutical and biotechnology companies have relied on BioIVT for quality in vitro products for lead optimization. We deliver faster time to results, so your research is more productive and cost-effective.
Our experience in preparing and shipping product ensures you of the highest quality primary cells and subcellular fractions for your research. BioIVT cryoplateable hepatocytes (the world's largest inventory) and other ADMET research tools are available worldwide. We also ship fresh plated hepatocytes throughout North America and to Western Europe.
Celerion
Celerion, a leader in early clinical research, delivers Applied Translational Medicine. Celerion applies our expertise and experience to translating information gained in research discoveries, to knowledge of drug action and effect in humans to support early drug development decisions and the clinical pharmacology labeling of new medicines.
With over 40 years of experience and 600 global clinic beds (including 24 in-hospital), Celerion conducts and analyzes First-in-Human, clinical Proof-of-Concept, Cardiovascular Safety Services (TQT, robust QT), ADME and NDA-enabling clinical pharmacology studies.
Celerion provides expertise on modeling and simulation, study design, medical writing (protocols and reports), clinical data sciences, biostatistics, and PK/PD analysis, in addition to small and large molecule bioanalytical assays throughout clinical drug development. Regulatory, drug development and program management complement Celerion’s service offerings.
For more information please visit www.celerion.com.
Charles River Laboratories
Charles River provides essential products and services to help pharmaceutical and biotechnology companies, government agencies and leading academic institutions around the globe accelerate their research and drug development efforts. Our dedicated employees are focused on providing clients with exactly what they need to improve and expedite the discovery, early-stage development and safe manufacture of new therapies for the patients who need them. To learn more about our unique portfolio and breadth of services, visit www.criver.com.
Frontage is a CRO providing integrated, scientifically-driven research, analytical and product development services throughout the drug discovery and development process to enable biopharmaceutical companies to achieve their drug development goals.
We offer our clients comprehensive services in analytical testing and formulation development, drug metabolism and pharmacokinetics (DMPK), bioanalysis, preclinical safety and toxicology and early phase clinical studies
Lonza
Lonza Bioscience Solutions is part of Lonza’s Pharma & Biotech segment. We provide life science researchers with the tools they need to develop and test therapeutics, from basic research to final product release. Our bioscience products and services range from cell culture and discovery technologies for research, to quality control tests and software for biomanufacturing. Bioscience Solutions serves research customers worldwide in pharmaceutical, biopharmaceutical and biotechnology companies, as well as academic and government research institutions. Our primary brands include Clonetics™ Primary Cells, BioWhittaker™ Media, RAFT™ 3D Cell Culture System, Nucleofector™ Transfection Technology, CytoSMART™ System for live cell imaging, MycoAlert™ Mycoplasma Detection Assay, PyroGENE™ rFC Endotoxin Detection Assay, WinKQCL™ Endotoxin Testing Analysis Software, MODA™ Environmental Monitoring Solutions.
Solvo Biotechnology
With 20 years of experience and 600 customers in more than 40 countries, SOLVO Biotechnology is the leading provider of transporter services and products. Leveraging our expertise in efflux and uptake transporters, SOLVO generates quality reports for submission to FDA/EMA. From small molecules to protein therapeutics, SOLVO can test all your transporter needs.
QPS
Founded in 1995, QPS is a GLP/GCP-compliant contract research organization (CRO) and life sciences products supplier supporting discovery, preclinical, and clinical drug development, providing quality services to pharmaceutical and biotechnology clients worldwide. QPS linearly integrated core competencies include: neuropharmacology, DMPK, liver research, toxicology, bioanalysis, translational medicine, and clinical development. QPS regional laboratories and (pre)clinical testing facilities are located at company headquarters in Newark, DE; Springfield, MO; Fargo, ND; Research Triangle Park, NC; Hollywood, FL; South Miami, FL, USA; Groningen, The Netherlands; Graz, Austria; Hyderabad, India; Barcelona, Spain; and Taipei, Taiwan.
Intrinsik
Intrinsik Corp., is a scientific and regulatory consulting firm providing expert toxicology and regulatory advice. We support the development of a wide range of human health products, including small molecules, biologics, natural health products, cosmetics and medical devices from the preclinical stage through to market and the post-approval phase.
Nuventra
Nuventra is a drug development consulting firm specializing in Pharmacokinetics, Pharmacodynamics, and Pharmacometrics. Our 30+ consultants, most with 15-30 years of experience, serve as a virtual extension of your team. More than just providing results from an analysis, our group helps make those results actionable and provides strategic guidance throughout your development program.
Who better to navigate the process than consultants who are familiar with the journey? Our scientists translate complex data into actionable insights across the entire drug development spectrum. With our background in clinical pharmacology and PK/PD, we enable our clients to make better strategic decisions and improve their clinical and nonclinical studies. Nuventra’s experts in pharmaceutical development consulting have more than 500 years of combined experience. Our specialized focus helps our clients avoid costly missteps and decrease the possibility of regulatory rejection.